Guideline on quality aspects included in the product information for vaccines for human use - Draft

We have adopted this International Scientific Guideline - EMA/CHMP/BWP/133540/2017

Last updated

9 January 2025

Adopted by the TGA: 28 February 2020

End of overseas consultation: 31 July 2018

Categories: Multidisciplinary | Vaccines

TGA Annotations: Nil

Where EU guidelines adopted in Australia include references to EU legislation (including EC Directives and Regulations), the requirements contained in the referenced EU legislation are not applicable to the evaluation of medicines by the TGA.
All documents and other content published by the European Medicines Agency (EMA) on this website are under the copyright and other intellectual property rights ownership of the EMA. Please refer to Legal notice | European Medicines Agency for further information.

Product types

Topics

Product regulation